Patients experiencing persistent gastrointestinal side effects that interfere with daily activities or nutritional intake may benefit from extending the duration at each dose level beyond the minimum four weeks before attempting further escalation
6 The popular GLP-1R agonist semaglutide Semaglutide is a long-acting GLP-1R agonist structurally similar to GLP-1 but resistant to proteolytic cleavage [96] and is given as a subcutaneous injection to patients with T2D
Ensure product reaches an internal temperature of 165 degrees F
Another major drug in this class is tirzepatide, sold as Mounjaro and Zepbound
Emphasize whole foods including vegetables, fruits, whole grains, and lean proteins while minimizing ultra-processed foods, added sugars, and excessive dietary fat
Another approach uses nasal spray for maintenance phases after an initial injection loading phase